IL15 and neoplasm: The in vivo delivery of transgene IL-15 into DC, which co-express full-length transgenic tumor Ag to allow for simultaneous DC presentation of Ag to T cells, may result in safer and more effective therapeutic vaccines that constitute an urgent, but as yet unmet, clinical need.